Your browser doesn't support javascript.
loading
OCT3/4 enhances tumor immune response by upregulating the TET1-dependent NRF2/MDM2 axis in bladder cancer.
Mao, Minghuan; Yang, Liang; Hu, Jingyao; Liu, Bing; Liu, Chunlai; Zhang, Xiling; Liu, Yili; Wang, Ping; Li, Hangyu.
Afiliação
  • Mao M; Department of Urology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China.
  • Yang L; Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China.
  • Hu J; Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China.
  • Liu B; Department of Urology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China.
  • Liu C; Department of Urology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China.
  • Zhang X; Department of Urology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China.
  • Liu Y; Department of Urology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China.
  • Wang P; Department of Urology, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China. Electronic address: wangping0268@163.com.
  • Li H; Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang 110000, PR China. Electronic address: sj_li_hangyu@163.com.
Genomics ; 113(4): 2122-2133, 2021 07.
Article em En | MEDLINE | ID: mdl-33894310

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article